No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 1.4x · 10Y median 1.8x · 37th percentile · as of Oct 6, 2026
Annualized revenue (TTM) · by quarter, last 27
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T16:57:24.217Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for LENSAR Inc (LNSR) stock was $6.71 as of Oct 6, 2026, 12:54 PM EDT, up 0.60% from the previous close.
Longer view (total return, dividends reinvested): past 12 months -45.1% · 3-year avg +31.5%/yr · 5-year avg -3.2%/yr
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision.
Medical - Devices · Orlando, FL
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Next Earnings Date
Nov 12, 2026
37 days away
EPS Estimate
-0.09
Revenue Est.
$14.29M
Last Quarter Results
EPS
$0.10
vs Estimate
$-0.27
Revenue
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1LNSR | $82.41M | $6.71 | +0.60% | -45.13% | -3.18% | N/A | N/A |
| 2MNOV | $82.45M | $1.68 | -4.56% | +37.29% | -13.62% | -13.11% | vs LNSR |
| 3ACRV | $82.82M | $1.94 | -2.27% | +3.65% | N/A | N/A | vs LNSR |
| 4CRDF | $83.24M | $1.08 | -5.26% | -47.78% | -30.36% | -43.20% | vs LNSR |
| 5PMN | $83.53M | $9.31 | -0.59% | -24.64% | -47.05% | -22.51% | vs LNSR |
| 6HUMA | $84.02M | $0.50 | +0.02% | -76.03% | -45.73% | N/A | vs LNSR |
N/A
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
$16.50M
vs Estimate
$14.65M
Consensus Rating
Based on 3 analysts
Average Price Target
$11.33
+68.9% upside
Low
$10.00
Current
$6.71
High
$13.00
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $-0.10 | $-0.09 | $-0.09 | 1 |
| Quarter ending Dec 2026 | $-0.07 | $-0.07 | $-0.07 | 1 |
| Quarter ending Mar 2027 | $-0.09 | $-0.09 | $-0.09 | 1 |
| Quarter ending Jun 2027 | $-0.06 | $-0.06 | $-0.06 | 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $0.01 | $0.01 | $0.01 | 1 |
| FY 2027 | $-0.24 | $-0.22 | $-0.21 | 1 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $14.19M | $14.29M | $14.39M | 3 |
| Quarter ending Dec 2026 | $16.80M | $17.06M | $17.30M | 3 |
| Quarter ending Mar 2027 | $16.34M | $16.60M | $16.83M | 1 |
| Quarter ending Jun 2027 | $18.38M | $18.67M | $18.92M | 1 |
Annual
| Period |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E is unavailable for the current price and estimate observations.
| Low |
|---|
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2026 | $60.99M | $61.29M | $61.59M | 3 |
| FY 2027 | $67.99M | $72.75M | $79.79M | 3 |
